• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

SoundHealth Launches First-Ever Real-Time Personalized Allergy Forecast

by Syed Hamza Sohail 09/17/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– SoundHealth, Inc. (“SoundHealth”), a medical technology company harnessing the power of artificial intelligence and medical science to improve patient outcomes, today introduced the first-ever personalized allergy forecast based on a person’s facial anatomy and their surrounding environment. 

– The SoundHealth SONU app uses patented AI algorithms to scan a user’s face and produce a real-time, personalized forecast of their allergy symptoms based on their location.

SONUCast: The World’s First AI-Powered Wearable for Allergy Forecasting and Treatment

SONUCast is the first system to pair with an FDA-approved wearable device to treat symptoms of allergic rhinitis, including nasal congestion, rhinorrhea (runny nose), and nasal itching caused by airborne particles in the nasal cavity. The wearable utilizes advanced Acoustic Resonance Therapy (ART) to deliver a non-pharmaceutical treatment for rhinitis, providing relief that is comparable to or better than nasal corticosteroids, without known side effects.

Powered by SoundHealth’s proprietary AI/ML algorithms, SONUCast can estimate internal sinonasal dimensions with a margin of error of less than 5% compared to CT scans. This technology enables real-time computational modeling and personalized predictions of nasal allergies. Once users scan their faces, SONUCast instantly generates a personalized allergy forecast based on their location, anywhere in the world.

SONUCast’s AI, trained on data from thousands of human subjects and hundreds of CT scans, is the first system designed for both allergy forecasting and ART. The wearable SONU band, approved by the FDA, provides a groundbreaking non-invasive solution for rhinitis treatment.

SoundHealth, the company behind SONUCast, is a medical technology firm focused on improving respiratory health through the power of artificial intelligence and medical science. The team at SoundHealth consists of experienced medical professionals, data scientists, and engineers committed to advancing healthcare. Investors in SoundHealth include Moai Capital, J4 Ventures, TeleSoft Partners, Tau Ventures, TechU Ventures, and Rhythm Venture Capital.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |